## **Core Concept**
Warfarin is an oral anticoagulant that works by inhibiting the synthesis of vitamin K-dependent clotting factors in the liver, specifically factors II, VII, IX, and X, and proteins C and S. The anticoagulant effect of warfarin can be influenced by various drugs that either induce or inhibit the cytochrome P450 system, particularly the CYP2C9 enzyme, which is responsible for warfarin metabolism.

## **Why the Correct Answer is Right**
The correct answer, , is associated with rifampicin, a rifamycin antibiotic used primarily in the treatment of tuberculosis. Rifampicin is a potent inducer of the cytochrome P450 enzyme system, including CYP2C9. By inducing CYP2C9, rifampicin increases the metabolism of warfarin, leading to decreased warfarin levels and a reduced anticoagulant effect. Therefore, rifampicin decreases the anticoagulant effect of warfarin, making it the correct exception in a list of drugs that increase warfarin's anticoagulant effect.

## **Why Each Wrong Option is Incorrect**
* **Option A:** is associated with cimetidine, a histamine H2-receptor antagonist that inhibits gastric acid production. Cimetidine can inhibit the CYP2C9 enzyme, reducing warfarin metabolism and increasing its anticoagulant effect.
* **Option B:** is associated with metronidazole, an antibiotic and antiprotozoal medication. Metronidazole can also inhibit the metabolism of warfarin, thereby increasing its anticoagulant effect.
* **Option D:** is associated with fluconazole, an antifungal medication. Fluconazole can inhibit CYP2C9, leading to decreased warfarin metabolism and an increased anticoagulant effect.

## **Clinical Pearl / High-Yield Fact**
A key clinical point to remember is that when drugs that affect warfarin's metabolism are initiated or discontinued, close monitoring of the International Normalized Ratio (INR) is crucial to adjust warfarin dosing accordingly and prevent thrombotic or bleeding complications.

## **Correct Answer:** . Rifampicin